BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 29914696)

  • 1. Role of complement C5a and histones in septic cardiomyopathy.
    Fattahi F; Frydrych LM; Bian G; Kalbitz M; Herron TJ; Malan EA; Delano MJ; Ward PA
    Mol Immunol; 2018 Oct; 102():32-41. PubMed ID: 29914696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement and sepsis-induced heart dysfunction.
    Fattahi F; Ward PA
    Mol Immunol; 2017 Apr; 84():57-64. PubMed ID: 27931779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement-induced activation of the cardiac NLRP3 inflammasome in sepsis.
    Kalbitz M; Fattahi F; Grailer JJ; Jajou L; Malan EA; Zetoune FS; Huber-Lang M; Russell MW; Ward PA
    FASEB J; 2016 Dec; 30(12):3997-4006. PubMed ID: 27543123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement-induced activation of MAPKs and Akt during sepsis: role in cardiac dysfunction.
    Fattahi F; Kalbitz M; Malan EA; Abe E; Jajou L; Huber-Lang MS; Bosmann M; Russell MW; Zetoune FS; Ward PA
    FASEB J; 2017 Sep; 31(9):4129-4139. PubMed ID: 28572445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New strategies for treatment of infectious sepsis.
    Ward PA; Fattahi F
    J Leukoc Biol; 2019 Jul; 106(1):187-192. PubMed ID: 30821872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of extracellular histones in the cardiomyopathy of sepsis.
    Kalbitz M; Grailer JJ; Fattahi F; Jajou L; Herron TJ; Campbell KF; Zetoune FS; Bosmann M; Sarma JV; Huber-Lang M; Gebhard F; Loaiza R; Valdivia HH; Jalife J; Russell MW; Ward PA
    FASEB J; 2015 May; 29(5):2185-93. PubMed ID: 25681459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement Destabilizes Cardiomyocyte Function In Vivo after Polymicrobial Sepsis and In Vitro.
    Kalbitz M; Fattahi F; Herron TJ; Grailer JJ; Jajou L; Lu H; Huber-Lang M; Zetoune FS; Sarma JV; Day SM; Russell MW; Jalife J; Ward PA
    J Immunol; 2016 Sep; 197(6):2353-61. PubMed ID: 27521340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction.
    Niederbichler AD; Hoesel LM; Westfall MV; Gao H; Ipaktchi KR; Sun L; Zetoune FS; Su GL; Arbabi S; Sarma JV; Wang SC; Hemmila MR; Ward PA
    J Exp Med; 2006 Jan; 203(1):53-61. PubMed ID: 16380509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement as a Major Inducer of Harmful Events in Infectious Sepsis.
    Fattahi F; Zetoune FS; Ward PA
    Shock; 2020 Nov; 54(5):595-605. PubMed ID: 32187106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Complement and Histones in Sepsis.
    Zetoune FS; Ward PA
    Front Med (Lausanne); 2020; 7():616957. PubMed ID: 33425963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harmful Roles of TLR3 and TLR9 in Cardiac Dysfunction Developing during Polymicrobial Sepsis.
    Fattahi F; Russell MW; Malan EA; Parlett M; Abe E; Zetoune FS; Ward PA
    Biomed Res Int; 2018; 2018():4302726. PubMed ID: 30364002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutting edge: critical role for C5aRs in the development of septic lymphopenia in mice.
    Grailer JJ; Fattahi F; Dick RS; Zetoune FS; Ward PA
    J Immunol; 2015 Feb; 194(3):868-72. PubMed ID: 25539817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement C5a Functions as a Master Switch for the pH Balance in Neutrophils Exerting Fundamental Immunometabolic Effects.
    Denk S; Neher MD; Messerer DAC; Wiegner R; Nilsson B; Rittirsch D; Nilsson-Ekdahl K; Weckbach S; Ignatius A; Kalbitz M; Gebhard F; Weiss ME; Vogt J; Radermacher P; Köhl J; Lambris JD; Huber-Lang MS
    J Immunol; 2017 Jun; 198(12):4846-4854. PubMed ID: 28490576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of C5 activation products in sepsis.
    Ward PA
    ScientificWorldJournal; 2010 Dec; 10():2395-402. PubMed ID: 21170490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation by C5a of neutrophil activation during sepsis.
    Riedemann NC; Guo RF; Bernacki KD; Reuben JS; Laudes IJ; Neff TA; Gao H; Speyer C; Sarma VJ; Zetoune FS; Ward PA
    Immunity; 2003 Aug; 19(2):193-202. PubMed ID: 12932353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement-induced impairment of innate immunity during sepsis.
    Huber-Lang MS; Younkin EM; Sarma JV; McGuire SR; Lu KT; Guo RF; Padgaonkar VA; Curnutte JT; Erickson R; Ward PA
    J Immunol; 2002 Sep; 169(6):3223-31. PubMed ID: 12218141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NOD2-mediated suppression of CD55 on neutrophils enhances C5a generation during polymicrobial sepsis.
    Oh SJ; Kim JH; Chung DH
    PLoS Pathog; 2013 May; 9(5):e1003351. PubMed ID: 23675299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The harmful role of c5a on innate immunity in sepsis.
    Ward PA
    J Innate Immun; 2010; 2(5):439-45. PubMed ID: 20588003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of the Complement Alternative Pathway in Serum Chemotactic Activity During Sepsis.
    Xu G; Feng Y; Li D; Zhou Q; Chao W; Zou L
    Shock; 2018 Oct; 50(4):435-441. PubMed ID: 29040213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory role of C5a on macrophage migration inhibitory factor release from neutrophils.
    Riedemann NC; Guo RF; Gao H; Sun L; Hoesel M; Hollmann TJ; Wetsel RA; Zetoune FS; Ward PA
    J Immunol; 2004 Jul; 173(2):1355-9. PubMed ID: 15240730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.